Coming soon to your clinic: Patient-friendly ART

Human Reproduction

Volumn 22, Issue 8, 2007, Pages 2075-2079

  Pennings, Guido ^a   Ombelet, Willem ^b  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF CARDIOLOGY   (Belgium)

Author keywords

Cost effectiveness; Ethics; Patient friendly IVF; Psychology; Risk

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADORELIN AGONIST; GONADOTROPIN DERIVATIVE; RECOMBINANT FOLLITROPIN;

ANXIETY DISORDER; ARTICLE; CHILD SAFETY; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG COST; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEADACHE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE PLANNING; HORMONAL REGULATION; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; INTRAUTERINE INSEMINATION; LOW BACK PAIN; MALE INFERTILITY; MATERNAL WELFARE; MEDICAL DECISION MAKING; MYALGIA; PREGNANCY RATE; REIMBURSEMENT; RISK MANAGEMENT; SOCIAL INSURANCE; TREATMENT OUTCOME; WELLBEING;

EID: 34547760838     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dem158     Document Type: Article

References (47)

1. Bayram N, van Wely M, van der Veen F, Bossuyt PM, Nieuwerk P. Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 2005;84:420-425.
2. Bitler M, Schmidt L. Health disparities and infertility: Impacts of state-level insurance mandates. Fertil Steril 2006;85 858-865.
3. Boivin J, Tafekman JE. Stress level across stages of in vitro fertilization in subsequently pregnant and non pregnant women. Fertil Steril 1995;64: 802-810.
4. Braat D, Kremer J. National experience with elective single-embryo transfer. D. The Netherlands. In Gerris J, Olivennes F, De Sutter P (eds). Assisted reproductive technologies: Quality and safety. Boca Raton, Parthenon Publishing Group, 2004, 123-125.
5. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, Goldman J, Kassirer JP, Kimball H, Naughton J, Smelner N. Health industry practices that create conflicts of interest. JAMA 2006; 295:429-433.
6. Collins JA, Bustillo M, Visscher RD, Lawrence LD. An estimate of the cost of in vitro fertilization services in the United States in 1995. Fertil Steril 1995;64:538-545.
7. Collins J, Graves G. The economic consequenses of multiple gestation pregnancy in assisted conception cycles. Hum Fertil 2000;3 275-283.
8. Collins J. An international survey of the health economics of IVF and ICSI. Hum Reprod Update 2002;8:265-277.
9. Dankert T, Kremer JA, Cohlen,BJ, Hamilton CJ, Pasker-de Jong PC, Straatman H, van Dop PA. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility. Hum Reprod 2007;22:792-797.
10. de Klerk C, Heijnen EM, Macklon NS, Duivenvoorden HI, Fauser BC, Passchier J, Hunfeld JA. The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod 2006;21:721-727.
11. Eijkemans MJ, Heijnen EM, de Klerk C, Habbema JD, Fauser BC. Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: Methodological considerations on a randomized controlled non-inferiority trial. Hum Reprod 2006;21:344-351.
12. ESHRE Task Force on Ethics and Law. Oocyte donation for non-reproductive purposes. Hum Reprod 2007;22:1210-1213.
13. Fauser BC, Devroey P, Yen SS, Gosden R, Crowley WF Jr, Baird DT, Bouchard P. Minimal ovarian stimulation for IVF: Appraisal of potential benefits and drawbacks. Hum Reprod 1999;14:2681-2686.
14. Gerris JM. Single embryo transfer and IVF/ICSI outcome: A balanced appraisal. Hum Reprod Update 2005;11:105-121.
15. Gnoth C, Godehardt D, Godehardt E, Frank-Herrmann P, Freundl G. Time to pregnancy: Results of the German prospective study and impact on the management of infertility. Hum Reprod 2003;18:1959-1966.
16. Goldfarb JM, Austin C, Lisbona. H, Peskin B, Clapp M. Cost-effectiveness of in vitro fertilization. Obstet Gynecol 1996;87 18-21.
17. Gordts S, Campo R, Puttemans P, Brosens I, Valkenburg M, Norré J, Renier M, Coeman D, Gordts S. Belgian legislation and the effect of elective single embryo transfer on IVF outcome. Reprod Biomed Online 2005;10:436-441.
18. Goverde AJ, McDonnell J, Vermeiden JP, Schats R, Rutten FF, Schoemaker J. Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: A randomized trial and cost-effectiveness analysis. Lancet 2000;355:13-18.
19. Griffin M, Panak WF. The economic cost of infertility-related services: an examination of the Massachusetts infertility insurance mandate. Fertil Steril 1998;70:22-29.
20. Guibert J, Olivennes F. Ovarian hyperstimulation syndrome: Prevention in IVF and non-IVF treatment. In Gerris J, Olivennes F, De Sutter P (eds). Assisted reproductive technologies: Quality and safety. Boca Raton, Parthenon Publishing Group, 2004. 169-180.
21. Hammarberg K. Stress in assisted reproductive technology: Implications for nurisng practice. Hum Fertil 2003;6:30-33.
22. Heijnen EM, Eijkemans MJ, De Klerk C, Polinder S, Beckers NG, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER et al. A mild treatment strategy for in-vitro fertilisation: A randomised non-inferiority trial. Lancet 2007;369:743-749.
23. Heijnen EMEW, Macklon NS, Fauser BCJM. What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: Consider the whole treatment. Hum Reprod 2004; 19:1936-1938.
24. Hojgaard. A, Ingerslev H, Dinesen J. Friendly IVF: Patient opinions. Hum Reprod 2001;16:1391-1396.
25. House of Commons Health Committee. The influence of the pharmaceutical industry. Fourth report of session 2004-05. Vol. I Report, together with minutes. London, The Stationary Office Limited, 2005.
26. Hughes EG, Giacomini M. Funding in vitro fertilization treatment for persistent subfertility: The pain and the politics. Fertil Steril 2001;76:431-442.
27. Janssens RMJ, Lambalk CB, Vermeiden JPW, Schats R, Schoemaker J. In-vitro fertilization in a spontaneous cycle: Easy, cheap and realistic. Hum Reprod 2000;15:314-318.
28. Kalu E, Thumn MY, Abdalla H. Intrauterine insemination in natural cycle may give better results in older women. J Assist Reprod Genet. 2007 [Epub ahead of print].
29. Klemetti R, Gissler M, Hemminki E. Equity in the use of IVF in Finland in the late 1990s. Scand J Public Health 2004;32:203-209.
30. Land JA, Evers JL. Risks and complications in assisted reproduction techniques: Report of an ESHRE consensus meeting. Hum Reprod 2003;18:455-457.
31. Laufer SZ, Levy R, Ben-Shushan D, Mor-Yosef S. Cost analysis of in vitro fertilization. Isr J Med Sci 1995; 31:492-496.
32. Miskry T, Chapman M. The use of intrauterine insemination in Australia and New Zealand. Hum Reprod 2002;17:956-959.
33. Nargund G, Waterstone J, Bland JM, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth raates in natural (unstimulated) IVF cycles. Hum Reprod 2001;16:259-262.
34. National Institute for Clinical Excellence (NICE). Assessment and treatment for people with infertility problems. Understanding NICE guidance - information for people with fertility problems, their partners and the public. London, NICE, 2004.
35. Olivius C, Friden B, Borg G, Bergh C. Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril 2004;81: 258-261.
36. Ombelet W, Vandeput H, Van de Putte G, Cox A, Janssen M, Jacobs P, Bosmans E, Steeno O, Kruger T. Intrauterine insemination after ovarian stimulation with clomiphene citrate:pRedictive potential of inseminating motile count and sperm morphology. Hum Reprod 1997;12: 1458-1463.
37. Ombelet W, Deblaere K, Bosmans E, Cox A, Jacobs P, Janssen M, Nijs M. Semen quality and intrauterine insemination. Reprod Biomed Online 2003;7:485-492.
38. Ombelet W, De Sutter P, Van der Elst J, Martens G. Multiple gestation and infertility treatment: RegistTation, reflection and reaction: the Belgian project. Hum Reprod Update 2005;11:3-14.
39. Paris JJ, Post SG. Managed care, cost control, and the common good. Camb Q Healthc Ethics 2000;9:182-188.
40. Pelinck MJ, Vogel NEA, Hoek A, Simons AHM, Arts AGJM, Mochtar MH, Beemsterboer S, Hondelink MN, Heineman MJ. Cumulative pregnancy rates after three cycles of minimal stimulation IVF and results according to subfertility diagnosis: A multicentre cohort study. Hum Reprod 2006;21:2375-2383.
41. Pennings G. Multiple pregnancies: A test case for the moral status of medically assisted reproduction. Hum Reprod 2000;15 2466-2469.
42. Pistorius END, Adang EMM, Stalmeier PFM, Braat DDM, Kremer JAM. Prospective patient and physician preferences for stimulation or no stimulation in IVF. Hum Fertil 2006;9:209-216.
43. Sovino H, Sir-Petermann T, Devoto L. Clomiphene citrate and ovulation induction. Reprod Biomed Online 2002;4:303-310.
44. Verhaak CM, Smeenk JM, Eugster A, van Minnen A, Kremer JA, Kraaimaat FW. Stress and marital satisfaction among women before and after their first cycle of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2001;76:525-531.
45. Vilska S, Tiitinen A, Hyden-Granskog C, Hovatta O. Elective transfer of one embryo results in an acceptable pregnancy rate and eliminates the risk of multiple birth. Hum Reprod 1999;14:2392-2395.
46. Wolner-Hanssen P, Rydhstroem H. Cost-effectiveness analysis of in-vitro fertilization: Estimated costs per successful pregnancy after transfer of one or two embryos. Hum Reprod 1998;13:88-94.
47. ZonMw. Vruchtbaarheidsstoornissen: Kansen voor doelmatiger zorg. Den Haag, ZonMw, 2005.